Skip to main content
TipRanks
Go Ultimate75% OFF

Arkema (AKE) AI Stock Analysis

36 Followers
FR:AKE

Arkema

(Paris:AKE)

Select Model
Rating:54Neutral
Price Target:EUR 59.00â–²(0.51% Upside)
Action:reiterated
Date:11/05/26

The score is held back primarily by weak profitability/returns and higher leverage despite the strong TTM revenue rebound, alongside a very high P/E that adds valuation risk. Technicals are mildly supportive with price above key moving averages, but momentum indicators are mixed and do not offset the fundamental and valuation headwinds.

Positive Factors
Differentiated Specialty MaterialsArkema’s focus on higher-value specialty materials and technical application support can deepen customer integration and make products harder to replace. Qualification processes and performance-based differentiation provide a durable basis for repeat demand and pricing resilience across industrial applications.
Negative Factors
Severe Profitability CompressionProfitability has weakened materially despite the revenue rebound, leaving net earnings near break-even. Lower gross, EBIT, and EBITDA margins reduce the buffer against operating pressure and make it harder for growth to translate into durable earnings or internally funded expansion.

Arkema (AKE) vs. iShares MSCI France ETF (EWQ)

-10%-5%0%5%10%15%20%25%30%FR:AKE+19.25%EWQ+0.40%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 4.44B
Dividend Yield
6.13%
Average Volume (3M)
184.90K
Price to Earnings (P/E)
53.4
Beta (1Y)
1.48
Revenue Growth
-1.70%
EPS Growth
-42.07%
Country
France
Employees
20,700
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Arkema Business Overview & Revenue Model

Company Description

Arkema S.A. operates as a global producer and distributor of specialty chemicals and advanced materials. Its operations are strategically divided into four key business segments: Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermed...

How the Company Makes Money

Arkema makes money primarily by manufacturing and selling specialty chemical products and materials to industrial customers, generating revenue through product sales contracts and recurring demand tied to customers’ manufacturing volumes. Its main re...

Arkema Financial Statement Overview

Summary

Revenue rebounded strongly (+37% TTM), but profitability is very weak with net margin around ~0.7% and lower gross/EBIT/EBITDA margins versus 2022–2024. Leverage has increased (debt-to-equity ~0.85 TTM) while returns have deteriorated (ROE ~1%). Cash flow is still positive (FCF ~€373M TTM) but trending weaker with softer conversion.

Income Statement

46Neutral

Balance Sheet

62Positive

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue8.90B9.07B9.54B9.51B11.55B9.52B
Gross Profit1.59B1.61B1.94B1.96B2.58B2.14B
EBITDA1.23B1.25B1.31B1.33B1.98B2.54B
Net Income60.00M63.00M354.00M402.00M965.00M1.31B
Balance Sheet
Total Assets14.17B14.24B15.21B14.52B13.51B12.30B
Cash, Cash Equivalents and Short-Term Investments1.47B2.20B2.01B2.04B1.59B2.29B
Total Debt4.27B5.36B4.55B4.28B3.26B2.76B
Total Liabilities7.21B8.01B7.45B7.06B6.17B5.95B
Stockholders Equity6.78B6.04B7.53B7.20B7.30B6.30B
Cash Flow
Free Cash Flow372.50M337.00M353.00M622.00M766.00M152.00M
Operating Cash Flow915.60M973.00M1.12B1.26B1.50B915.00M
Investing Cash Flow-535.60M-616.00M-940.00M-1.35B-2.34B473.00M
Financing Cash Flow-220.60M-262.00M-207.00M516.00M168.00M-652.00M

Arkema Technical Analysis

Technical Analysis SentimentPositive
Last Price58.70

Price Trends

50DMA56.38Positive
100DMA57.23Positive
200DMA56.95Positive

Market Momentum

MACD0.60Negative
RSI63.41Neutral
STOCH59.24Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:AKE, the sentiment is Positive. The current price of 58.70 is above the 20-day moving average (MA) of 56.33, above the 50-day MA of 56.38, and above the 200-day MA of 56.95, indicating a bullish trend. The MACD of 0.60 indicates Negative momentum. The RSI at 63.41 is Neutral, neither overbought nor oversold. The STOCH value of 59.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:AKE.

Arkema Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

FR:AKE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:AIFR:AI63NeutralEUR 121.23B32.9013.42%1.59%-1.30%3.05%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
FR:AKEFR:AKE54NeutralEUR 4.44B53.361.28%6.13%-1.70%-42.07%
FR:ALCRBFR:ALCRB46NeutralEUR 85.86M-4.12-10.62%―――
FR:ALAFYFR:ALAFY35UnderperformEUR 86.25M-11.27-7.49%―-13.62%54.46%

* General Sector Average

Performance Comparison

0%50%100%150%FR:AKEFR:AIFR:ALCRBFR:ALAFYFR:ALDUBFR:MLPRXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
FR:AKE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
FR:AKEArkema SA (UK)58.708.3916.68%
FR:AIAir Liquide (UK)192.1638.0124.66%
FR:ALCRBCarbios SA4.90-3.75-43.35%
FR:ALAFYAFYREN2.23-0.17-7.29%
FR:ALDUBEncres Dubuit SA1.84-0.48-20.69%
FR:MLPRXParx Materials NV0.400.1560.00%

Arkema Corporate Events

Arkema’s Specialty Materials Drive Third-Quarter Growth

Nov 5, 2026

Arkema, a specialty chemicals producer focused on advanced materials and applications in growth markets, reported stronger third-quarter results despite generally weak demand. Revenue rose 8.1% to €2.4 billion, while EBITDA increased 7.0% to €332 mil...

Arkema Wins Validation for 2035 and 2050 Climate Targets

Nov 3, 2026

Arkema develops specialty materials, including adhesives, advanced materials and coating solutions, with a focus on sustainable applications in energy, water, recycling, urbanization and mobility. The Group operates in about 55 countries and aims to...

Arkema Employees Boost Stake in €45 Million Share Issue

Oct 27, 2026

Arkema has completed its tenth employee share capital increase since its listing 20 years ago, with nearly 34% of group employees participating and total subscriptions of about €45 million, resulting in new shares equivalent to 1.3% of the company’s...

Arkema boosts low-carbon acrylic leadership with major Carling investment

Oct 8, 2026

Arkema has inaugurated a new acrylic acid purification unit at its Carling site in France, using an innovative process that improves energy efficiency by 25% and cuts the site’s carbon intensity by 20%. The nearly €150 million investment, partly fund...

Arkema Reports Share Buyback Transaction on Euronext Paris

Oct 6, 2026

Arkema disclosed that it executed a share repurchase operation on 28 September 2026, buying 3,300 of its own shares on the Euronext Paris market at a daily weighted average price of €56.4598. The transaction was carried out under the conditions of Ar...

Arkema Updates Share Capital and Voting Rights Structure as of September 2026

Oct 5, 2026

Arkema has reported that as of September 30, 2026, the company has 76,060,831 shares outstanding, with a total of 95,372,290 voting rights when including treasury shares. When excluding shares held by the company itself, the total number of voting ri...

Arkema Boosts Global Battery R&D With €10 Million Expansion in France

Oct 1, 2026

Arkema is a global specialty materials company that develops advanced materials, adhesive solutions and coating solutions for high-growth sectors including new energies, water treatment, recycling and sustainable mobility. With a diversified portfoli...

Arkema Discloses Late-September Share Buybacks on Euronext Paris

Sep 29, 2026

Arkema reported a series of share buyback transactions carried out between 21 and 25 September 2026 on Euronext Paris, repurchasing a total of 17,600 shares at a weighted average price of about €56.85. The operations, disclosed under EU market abuse...

Arkema strengthens specialty materials push with new deputy CEO for polymers and gases

Sep 28, 2026

Arkema has appointed François Desné as Deputy Chief Executive Officer of High Performance Polymers and Fluorinated Gases and member of the Group Executive Committee, effective October 12, 2026. He replaces Laurent Tellier, who became Chief Operating...

Arkema Discloses September 2026 Share Buyback Transactions on Euronext Paris

Sep 22, 2026

Arkema has disclosed a new series of share buyback transactions carried out on the Euronext Paris market between 14 and 18 September 2026 under the framework of EU market abuse regulations. Over this five-day period, the company repurchased a total o...

Arkema Details September Share Buyback Transactions on Euronext Paris

Sep 15, 2026

Arkema has disclosed a series of share buyback transactions carried out on the Euronext Paris exchange between 7 and 11 September 2026. Over this period, the group repurchased a total of 17,700 shares at a weighted average price of €58.3610, with dai...

Arkema Reports Early September Share Buybacks Under EU Market Rules

Sep 8, 2026

Arkema disclosed that it executed a series of share buybacks on the Euronext Paris market between 1 and 4 September 2026. Over these four sessions the company repurchased a total of 12,800 shares of its own stock, with a weighted average acquisition...

Arkema Details August Share Buybacks on Euronext Paris

Sep 1, 2026

Arkema disclosed recent share buyback activity on Euronext Paris, repurchasing a total of 9,600 shares between 24 and 25 August 2026 at a daily weighted average price of about €59 per share. The transactions, carried out under EU market abuse regulat...

Arkema Buys Back 25,000 Shares on Paris Market Under Ongoing Program

Aug 25, 2026

Arkema disclosed that it repurchased 25,000 of its own shares on the Paris market between 17 and 21 August 2026, at a weighted average price of €60.12 per share, in accordance with European market abuse regulations. The buybacks form part of the grou...

Arkema details August share buybacks on Euronext Paris

Aug 18, 2026

Arkema has disclosed a new series of share buyback transactions conducted on the Euronext Paris market between August 10 and August 14, 2026, in line with European market-abuse regulations. Over the period, the group repurchased a total of 17,900 sha...

Arkema Repurchases 17,500 Shares in August Buyback Tranche

Aug 11, 2026

Arkema has reported a new series of share buybacks conducted between 3 and 7 August 2026 on the Paris market, repurchasing a total of 17,500 shares at a weighted average price of €61.27. The transactions, executed under the European market abuse regu...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 04, 2026